M. Ferrer Monreal (Barcelona, Spain), A. Torres (Barcelona, Spain), I. Martin-Loeches (Dublin 8, Ireland), M. Restrepo (San Antonio, United States of America)
Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study D. Feng (Guang zhou, China)
| |
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Z. Zhao (Beijing, China)
| |
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia M. Sano (Nagoya, Japan)
| |
Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables A. Lacoma De La Torre (Badalona (Barcelona), Spain)
| |
Predictors of mortality in VAP following cardiac surgery – adult and pediatric K. Supraja (CHENNAI (TAMIL NADU), India)
| |
The impact of septic shock on intensive care unit-acquired pneumonia survival is not homogenous O. Tavares Ranzani (Sao Paulo/Sp, Brazil)
| |
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study C. Cilloniz Campos (Barcelona, Spain)
| |
Sepsis related to pneumonia after renal transplantation V. Pencheva (Sofia, Bulgaria)
| |
Clinical Utility of Different Methods In Diagnosis Of Pulmonary Cryptococosis In Patients Without HIV Infection Y. Li (wenzhou, China)
| |
Cell-mediated immunity in patients with Pneumocystis jirovecii pneumonia G. Parrott (Okinawa City, Japan)
| |
Prevalence and risk factors for pulmonary aspergillosis infection in thoracic oncology: a 5 years retrospective study J. Cuilleron (LYON, France)
| |
Clinicopathologic features of pulmonary Cryptococcus Y. Choi (Gwangju, Republic of Korea)
| |
Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute K. Agarwal (DELHI (NEW DELHI), India)
| |
Pneumocystis jirovecii pneumonia, study of 26 cases S. Calero Pardo (Madrid, Spain)
| |
Lung Cancer and bronchial infection P. Bruno (ROMA, RM, Italy)
| |
Mortality and prognostic factors of necrotizing community acquired pneumonia (NCAP) in a general hospital M. Solis Aramayo (Ciudad Autónoma Buenos Aires, Argentina)
| |
Microorganisms resistant to conventional antimicrobial treatment in acute exacerbation of COPD C. Estirado (BARCELONA, Spain)
| |
Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD A. Mohamed-Hussein (Assiut, Egypt)
| |
The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients. M. Paplinska-Goryca (Warszawa, Poland)
| |